Found 267 matching trials
SPI-1005 for the Treatment of Meniere's Disease (Open Label)
PHASE3Study of the safety of open-label SPI-1005 400 mg BID treatment in adults w...
Status
Active Not Recruiting
Location
The House Institute
Therapeutics for Moderate and Severe Dengue
PHASE3The purpose of this multi-site, factorial randomised, platform trial is to ...
Location
Chittagong Medical College Hospital
Evaluation of the Role of N Acetyl Cysteine and Vitamin D in Improving Outcomes After Corrosive Ingestion
PHASE3The goal of this clinical trial is to learn if N acetyl cysteine and vitami...
Status
Active Not Recruiting
Location
Ain Shams University
Study of (Telintra®) in Non-Del(5q) Myelodysplastic Syndrome
PHASE2This is a multicenter, single arm open label Phase 2b Study of oral ezatios...
Location
Bay Area Cancer Research Group
Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLC
PHASE1Chemotherapeutic agents exert significant immunomodulatory effects by influ...
Location
the First Affiliated Hospital of Zhengzhou University
The Role of Glutathione Deficiency and MSIDS Variables in Long COVID-19
EARLY_PHASE1The purpose of this research study is to assess if glutathione, along with ...
Location
University of California Irvine Medical Center
Effect of Vitamin C Upon SSRI-treated OCD Patients
NATitle:
Effect of Vitamin C upon Selective Serotonin Reuptake Inhibitors (S...
Phase 2 Study Comparing Two Dose Schedules of Telintra™ in Myelodysplastic Syndrome (MDS)
PHASE2This is a randomized, open label, multicenter, Phase 2 study comparing two ...
Location
Arizona Cancer Center
Efficacy of Na-GST-1/Alhydrogel Hookworm Vaccine Assessed by Controlled Challenge Infection
PHASE2This study evaluates the efficacy, safety and immunogenicity of different f...
Location
George Washington University
Clinical and Pharmacological Study With 2B3-101 in Patients With Breast Cancer and Leptomeningeal Metastases
PHASE2Leptomeningeal metastases (LM) develop when tumor cells reach the cerebrosp...
Location
the Netherlands Cancer Institute - Antoni van Leeuwenhoek